”AI som både imponerar och skrämmer”

"Tidigare har jag sällan varit särskilt imponerad över något som varit AI-producerat. Men det här är något helt annat", skriver Samuel Lagercrantz i en ledare o...

Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap

From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...

New diagnostic test soon ready for the market

Event: Drug Development – Serendipity or Science

Drug development is a challenging journey, we will discuss questions you may not even consider asking. SDS and Medicon Village welcome you to an engaging afternoon.

The first pharmaceutical for eosinophilic esophagitis approved in the U.S.

The U.S. Drug Administration has approved the drug Dupixent (dupilumab) to treat inflammation of the oesophagus of the type eosinophil esophagitis.

En återfödelse i innovationens namn

DMC Automation från Turin har skapat en robotenhet som är utrustad med komponenter från SMC innehållande ett innovativt trådlöst styrsystem. Detta är ett stabil...

This is how Anette Steenberg will put Medicon Valley on the world map

Anette Steenberg has been CEO of the Swedish-Danish life science cluster Medicon Valley Alliance since 1 November last year. Life Science Sweden called her to a...

Samuel Lagercrantz: Collaboration and joint efforts are the key to success

Although many questions about Covid-19 remain unanswered, the development of drugs and vaccines has been incredibly rapid, writes Samuel Lagercrantz, Life Scien...

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

Björn Ursing: Physicians new role in AI driven healthcare

”AI could be the key we need for tomorrow’s healthcare, but it is not a stand-alone tool”, writes Björn Ursing in a column about how the role for physicians cha...

KI i open innovation-samarbete

Genom projektet Ultra-DD ska tidig läkemedelsutveckling bli mer effektiv.

ARM-D – Vill du spara plats i din maskin?

Nya modulära regulatorn ARM-D ger ett ytterst kompakt montage för samtidig reglering av flera tryck.

The route to vaccines for everyone: “We did not just sit around and wait”

The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a propos...

Apple satsar på life science

Lanserar plattform för utveckling av appar som kan hjälpa forskare att samla in data och rekrytera patienter till kliniska studier.

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Newly discovered gene variant linked to protection against abdominal obesity

American researchers believe they have identified a rare gene mutation that protects against abdominal obesity and metabolic syndrome. The ambition is that the ...

Norway finds its path in life science

The life science sector in Norway is on the rise.

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...

Column: Repurposing as a golden ticket to approval

"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...

Läkare vid Karolinska presenterar rön som kan ge bättre behandling av leukemi

Forskare vid Karolinska universitetssjukhuset har hittat en metod för mer effektiv behandling av aggressiv blodcancer, enligt en ny studie.

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

GSK öppnar substansbibliotek

Läkemedelsjätten Glaxosmithkline har bestämt sig för att offentliggöra 200 av sina mest lovande substanser mot TBC.

Björn Arvidsson: Let's build on the positive momentum

Progress needs narratives and heroes, and more than ever, going into the new year feels like an opportunity for a fresh start.

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.